CD4 and tuberculosis: Of the 45 (51.2%; 95% CI: 46.6–55.9) patients with TB who had a documented initial CD4 cell count ≥100 cells/μL and who received two Xpert MTB/RIF tests, 22 (49.2%; 95% CI: 38.9–59.4) had a spot specimen that tested positive and 25 (56.0%; 95% CI: 46.2–65.8) had a morning specimen that tested positive; eight (35.0%; 95% CI: 17.2–52.8) additional patients were diagnosed by testing the morning specimen after the spot specimen.